Positive results in intermediate and advanced disease come after the failure of global trials investigating the combination of TACE with targeted agents
Integrated, comprehensive databases may help to close the gap in cancer care between high- and low-/lower-middle-income countries
Final overall survival results are now awaited to confirm the place of the combination treatment as a standard approach
Differences in cancer population, local expertise, availability of and accessibility to treatments are incorporated into two new Pan-Asian adaptations (PAGA) of the ESMO Clinical Practice Guidelines
An easy-to-use method to detect dysbiosis may help guide selection of cancer treatments and microbiota-centred interventions
Tailored strategies based on existing technologies and digital tools are needed to help inform people in geographically difficult-to-reach communities
While some challenges associated with rare cancers are similar in Europe and Asia, resources and differing epidemiology need to be considered when coming up with solutions
Results from a pilot study show that work–family balance is the biggest challenge to career progression for young women
There is a broader negligence of the public health consequences of individual actions among the health providers
Findings suggest that analysis of multiple prostate diagnostic biopsy cores, in contrast to frequent practice, may help reduce tumour mischaracterisation and identify genetic alterations relevant to personalised treatment
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.